| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.03 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.04 |